Clinical Trial Update: Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating torcetrapib in combination with atorvastatin for familial hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• Lipitor (atorvastatin)
• Torcetrapib (torcetrapib)

Snippet

Sponsor: Pfizer | Conditions: Hypercholesterolemia, Familial | Phase 3 | Status: COMPLETED